Int J Cardiol Heart Vasc. 2019 Jul 10;24:100396. doi: 10.1016/j.ijcha.2019.100396. eCollection 2019 Sep.
Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs.
International journal of cardiology. Heart & vasculature
Hiroko Takahama, Hiroshi Asanuma, Osamu Tsukamoto, Shin Ito, Masafumi Kitakaze
Affiliations
Affiliations
- Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
- Department of Cell Biology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
- Department of Molecular Imaging in Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan.
- Department of Internal Medicine, Meiji University of Integrative Medicine, Hiyoshicho, Nantan, Kyoto, Japan.
- Department of Medical Biochemistry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan.
PMID: 31334333
PMCID: PMC6620623 DOI: 10.1016/j.ijcha.2019.100396
Abstract
BACKGROUND: Endogenous adenosine levels increase under stress in various organs. Exogenously administered adenosine is a well-known pulmonary vasodilator. However, the physiology and therapeutic potential of endogenous adenosine during alteration in pulmonary hemodynamics such as pulmonary embolism is not elucidated. We hypothesized that the adenosine level increases following an acute elevation of pulmonary resistance, resulting in pulmonary vasodilation.
METHODS: We induced acute pulmonary embolization by injecting plastic beads in anesthetized dogs. Plasma adenosine levels, defined as the product of plasma adenosine concentration and simultaneous cardiac output, were assessed from blood samples from the superior vena cava, main pulmonary artery (MPA), and ascending aorta 1 and 10 min following injection. Hemodynamics were assessed with (
RESULTS: Mean pulmonary arterial pressure (PAP) increased from 11 ± 1 mmHg, peaking at 28 ± 4 mmHg at 52 ± 13 s after injection. During this period, total pulmonary resistance (TPR) elevated from 11 ± 1 to 33 ± 6 Wood unit. Plasma adenosine levels increased in the MPA from 14.5 ± 2 to 38.8 ± 7 nmol/min 1 min after injection. TPR showed greater elevation under 8SPT treatment, to 96 ± 12 Wood unit at PAP peak.
CONCLUSIONS: Endogenously released adenosine after acute pulmonary embolization is one of the initial pulmonary vasodilators. The immediate surge in plasma adenosine levels in the MPA could lead to a hypothesis that adenosine is released by the right heart in response to pressure overload.
Keywords: Adenosine; Hemodynamics; Pulmonary embolization; Vasodilation
Conflict of interest statement
Drs. Takahama, Asanuma, Tsukamoto, Ito have no conflict of interest. Kitakaze reports grants and personal fees from Takeda, during the conduct of the study; grants from Japanese government, grants fro
References
- Chest. 2002 Mar;121(3):877-905 - PubMed
- Physiology (Bethesda). 2009 Oct;24:298-306 - PubMed
- Am J Physiol. 1995 May;268(5 Pt 2):H1862-8 - PubMed
- Am J Physiol. 1975 Dec;229(6):1625-31 - PubMed
- Nat Med. 2011 Jan;17(1):79-86 - PubMed
- Pharmacol Ther. 2013 Oct;140(1):92-111 - PubMed
- Life Sci. 1981 Jun 8;28(23):2631-41 - PubMed
- Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1633-40 - PubMed
- Crit Care Med. 2013 Jul;41(7):e118-24 - PubMed
- Cardiovasc Res. 2000 Oct;48(1):23-33 - PubMed
- J Mol Med (Berl). 2013 Feb;91(2):183-93 - PubMed
- Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1731-7 - PubMed
- J Mol Cell Cardiol. 2000 Mar;32(3):345-54 - PubMed
- Am J Physiol. 1984 Oct;247(4 Pt 2):H541-7 - PubMed
- Circulation. 1991 Sep;84(3):1145-9 - PubMed
- J Thromb Haemost. 2009 Sep;7(9):1597-9 - PubMed
- Am J Physiol. 1994 Feb;266(2 Pt 2):H521-30 - PubMed
- Circulation. 2006 Sep 26;114(13):1417-31 - PubMed
- Clin Chem. 1992 Feb;38(2):256-62 - PubMed
- J Clin Invest. 1992 Mar;89(3):909-18 - PubMed
- J Mol Cell Cardiol. 1978 Mar;10(3):293-300 - PubMed
- Compr Physiol. 2012 Jan;2(1):711-41 - PubMed
- Blood. 2004 Dec 15;104(13):3986-92 - PubMed
- Pharmacol Ther. 2001 Aug;91(2):133-47 - PubMed
- Pulm Pharmacol Ther. 2012 Feb;25(1):48-54 - PubMed
- Shock. 2008 Feb;29(2):197-204 - PubMed
- Med Hypotheses. 2009 Jun;72(6):713-9 - PubMed
- J Am Coll Cardiol. 2009 Jul 28;54(5):375-85 - PubMed
- Blood. 2008 Feb 15;111(4):2024-35 - PubMed
- Am J Cardiol. 1997 Jun 19;79(12A):2-10 - PubMed
- Circulation. 1995 Feb 1;91(3):838-44 - PubMed
- Am J Physiol. 1998 Nov;275(5):H1663-72 - PubMed
- Am J Physiol. 1992 Jul;263(1 Pt 1):L73-8 - PubMed
- Ann Biomed Eng. 2014 Aug;42(8):1631-43 - PubMed
- Nat Rev Drug Discov. 2013 Apr;12(4):265-86 - PubMed
- J Appl Physiol (1985). 1989 May;66(5):2079-83 - PubMed
- J Immunol. 2007 Jun 15;178(12):8127-37 - PubMed
- Eur Heart J. 2008 Sep;29(18):2276-315 - PubMed
- Am J Physiol. 1989 Apr;256(4 Pt 1):C799-806 - PubMed
- Am J Physiol. 1982 Jan;242(1):H24-9 - PubMed
- J Appl Physiol (1985). 2010 Nov;109(5):1307-17 - PubMed
- Am J Physiol. 1996 Jan;270(1 Pt 2):H200-7 - PubMed
- Crit Care Med. 2011 Dec;39(12):2700-4 - PubMed
- Pharmacol Ther. 2008 Sep;119(3):242-63 - PubMed
- Circulation. 2006 Jul 11;114(2):e28-32 - PubMed
Publication Types